Results 21 to 30 of about 29,799 (243)

Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease

, 2012
BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease.
Christopher J Cates, Karner, C, Cates, CJ, Charlotta Karner   +3 more
core   +1 more source

Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease [PDF]

, 2011
Background Long-acting beta2-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However,
David J Evans, Spencer, Sally, Spencer, S, Evans, David, Karner, C, Cates, CJ, Charlotta Karner, Christopher J Cates, Sally Spencer, Karner, Charlotta, Evans, DJ, Cates, Christopher, Spencer, Sally; id_orcid   +12 more
core   +1 more source

A review of practical strategies for managing bronchial asthma in conventional medical systems

Indian Journal of Allergy Asthma and Immunology
Bronchial asthma is a chronic airway condition affecting about 10%–12% of adults and 15% of children worldwide. Treatment guidelines vary by asthma nature and severity.
Khadija Abdul Hafiz, Kaleem Ahmad, Mohd Aleemuddin Quamri   +2 more
doaj   +1 more source

Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

Respiratory Research, 2020
Background The comparative efficacy of inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist (ICS/LAMA/LABA) triple therapy administered via single or multiple inhalers in patients with chronic obstructive pulmonary disease ...
Gary T. Ferguson, Nicola Brown, Chris Compton, Thomas C. Corbridge, Kelly Dorais, Charles Fogarty, Catherine Harvey, Morrys C. Kaisermann, David A. Lipson, Neil Martin, Frank Sciurba, Marjorie Stiegler, Chang-Qing Zhu, David Bernstein   +13 more
doaj   +1 more source

Combination inhaled steroid and long-acting beta-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease (Review)

, 2011
Background The long-acting bronchodilator tiotropium and single inhaler combination therapy of inhaled corticosteroids and long-acting beta(2)-agonists are both commonly used for maintenance treatment of chronic obstructive pulmonary disease.
Christopher J Cates, Karner, C, Cates, CJ, Charlotta Karner   +3 more
core   +1 more source

Addressing unmet needs in the treatment of COPD [PDF]

European Respiratory Review, 2014
The burden of chronic obstructive pulmonary disease (COPD) is considerable, both socially and economically. Central to COPD management is the use of long-acting bronchodilators, which provide patients with optimal bronchodilation and improvements in ...
Francesco Patalano, Donald Banerji, Peter D’Andrea, Robert Fogel, Pablo Altman, Paul Colthorpe   +5 more
doaj   +1 more source

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease

, 2010
Background Combination therapy (inhaled corticosteroids and long-acting beta(2)-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD).
Christopher J Cates, Emma J Welsh, Welsh, EJ, Phillippa Poole, Cates, CJ, Poole, P   +5 more
core   +1 more source

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)

Health Technology Assessment, 2011
Objectives: To evaluate, under real-life practice conditions in UK primary care, asthma control and cost-effectiveness of commencing therapy with leukotriene antagonists compared with inhaled corticosteroids (ICSs) as initial controller therapy and ...
D Price, S Musgrave, E Wilson, E Sims, L Shepstone, A Blyth, J Murdoch, M Mugford, E Juniper, J Ayres, S Wolfe, D Freeman, A Lipp, R Gilbert, I Harvey   +14 more
doaj   +1 more source

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease.

, 2011
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Developments in the understanding of COPD have led to standard guidelines for diagnosis, treatment, and spirometry assessments, which have in turn ...
James Donohue, Paul Jones, James F Donohue, Paul W Jones, Donohue, JF, Jones, PW   +5 more
core   +1 more source

The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma – A targeted literature review

Annals of Thoracic Medicine, 2023
Inhaler combination formulations consisting of an inhaled corticosteroid (ICS) (fluticasone propionate) and a long-acting β2 agonist (salmeterol xinafoate) are indicated as maintenance treatments for patients with asthma and/or for selected patients with
Amr S Albanna, Mohammed Alhajji, Waleed Alsowayan, Mohamed Hany Soliman   +3 more
doaj   +1 more source